Khanna A, Jopson L, Blamire AM, et al. Effects of B-Cell depleting therapy (Rituximab) on liver biochemistry in UDCA-responsive patients: results from a randomised controlled trial of Rituximab in fatigued PBC patients (RitPBC). AASLD 2017, abstract 72.
IBD-patiënten hebben geen verhoogd risico op ernstig COVID-19
okt 2021 | IBD